XML 18 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
Research and development expenses $ 3,378 $ 90
General and administrative expenses 12,041 5,172
Total operating costs and expenses 15,419 5,262
Operating loss (15,419) (5,262)
Other income (expenses):    
Other income (expense), net (890) 4,923
Interest income 13 15
Interest expense, net (1,506) (211)
Total other (expense) income, net (2,383) 4,727
Net income (loss) (17,802) (535)
Less: Change in fair value and income impact of option liabilities (5,521)
Net income (loss) - diluted $ (17,802) $ (6,056)
Basic earnings/(net loss) per share $ (20.53) $ (0.79)
Diluted earnings/(net loss) per share $ (20.53) $ (8.92)
Basic weighted-average common shares outstanding 867,096 669,739
Diluted weighted-average common shares outstanding 867,096 678,939
Comprehensive income (loss):    
Foreign currency translation adjustment $ 3 $ (264)
Total comprehensive income (loss) $ (17,799) $ (799)